Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SCRT1 is a novel beta cell transcription factor with insulin regulatory properties.

Molecular and cellular endocrinology·2020

Same author

Ghrelin suppresses insulin secretion in human islets and type 2 diabetes patients have diminished islet ghrelin cell number and lower plasma ghrelin levels.

Molecular and cellular endocrinology·2020

Same author

Phenotypic and genotypic differences between Indian and Scandinavian women with gestational diabetes mellitus.

Journal of internal medicine·2019

Same author

Precision medicine in type 2 diabetes.

Journal of internal medicine·2018

Same author

Coffee consumption, genetic susceptibility and risk of latent autoimmune diabetes in adults: A population-based case-control study.

Diabetes & metabolism·2018

Same author

Insulin secretion and action in North Indian women during pregnancy.

Diabetic medicine : a journal of the British Diabetic Association·2017

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Genetic basis of beta-cell dysfunction in man.

L Groop¹, V Lyssenko

¹Department of Clinical Sciences/Diabetes and Endocrinology, and Lund University Diabetes Centre, Lund University, University Hospital Malmoe, Sweden. Leif.Groop@med.lu.se

Diabetes, Obesity & Metabolism

|October 13, 2009

Summary

Whole genome wide association studies have revolutionized the understanding of type 2 diabetes (T2D) genetics. Future research will further clarify T2D

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Isolation of Human Islets from Partially Pancreatectomized Patients

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Related Experiment Videos

Last Updated: Jun 19, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Isolation of Human Islets from Partially Pancreatectomized Patients

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Area of Science:

Genetics
Endocrinology
Metabolic Diseases

Background:

Identifying genetic causes for monogenic disorders is established.
Dissecting the genetics of complex polygenic diseases like type 2 diabetes (T2D) has been challenging.
Whole genome wide association studies (WGAS), introduced in 2007, have significantly advanced T2D genetic research.

Purpose of the Study:

To review the advancements in understanding the genetic architecture of type 2 diabetes.
To highlight the impact of WGAS on identifying T2D susceptibility variants.
To anticipate future directions in T2D genetic research.

Main Methods:

Review of genetic association studies, particularly WGAS.
Analysis of identified genetic variants associated with T2D risk.
Discussion of emerging genetic and epigenetic factors.

Main Results:

Approximately 20 genetic variants linked to T2D risk are currently known.
Most identified variants affect beta-cell function in response to increased body weight and insulin resistance.
Current findings represent initial insights, with more complex genetic factors yet to be uncovered.

Conclusions:

WGAS have transformed the study of T2D genetics.
Future research using refined tools will provide a comprehensive view of T2D genetic complexity.
The genetic basis of complex diseases like T2D is increasingly becoming dissectible.